HomeInsightsResults

Global Health Ltd Quarterly Result

Global Health Ltd Quarterly Result

stocks purchased

₹ 0.5 Cr

Volume Transacted

(Nov 22, 2024)

stocks purchased

4.8 K

Stocks Traded

(Nov 22, 2024)

Last Updated on: Nov 22, 2024

Image

Global Health Ltd

NSE: MEDANTA

Net Profit

₹ 130.82

Last updated on: Nov 22, 2024

Key Highlights

  • The revenue of Global Health Ltd for the Sep '24 is ₹ 974.77 crore as compare to the Jun '24 revenue of ₹ 883 crore. This represent the growth of 10.392981%.
  • The ebitda of Global Health Ltd for the Sep '24 is ₹ 246.5 crore as compare to the Jun '24 ebitda of ₹ 208.25 crore. This represent the growth of 18.367348%.
  • The net profit of Global Health Ltd for the Sep '24 is ₹ 130.82 crore as compare to the Jun '24 net profit of ₹ 106.26 crore. This represent the growth of 23.113123%.

Results Analysis

Market Price of Global Health Ltd

1M

1Y

3Y

5Y

Monitoring Global Health Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
21 Nov 20241072.45
19 Nov 20241086.4
18 Nov 20241080.4
14 Nov 20241071.1
13 Nov 20241035.45
12 Nov 20241060.75
11 Nov 20241070.4
08 Nov 20241067.85
07 Nov 20241085.55
06 Nov 20241073.35

Historical Revenue of Global Health Ltd

No data available

* All values are in crore

Historical EBITDA of Global Health Ltd

No data available

* All values are in crore

Historical Net Profit of Global Health Ltd

No data available

* All values are in crore

Global Health Ltd News Hub

News

Global Health announces board meeting date

Global Health will hold a meeting of the Board of Directors of the Company on 14 November ...

Read more

08 Nov 202415:32

News

Medanta signs O&M agreement for 750 bed hospital in Pitampura, New Delhi

Global Health announced that the Company has signed an Operations and Management Agreement...

Read more

06 Nov 202418:41

News

Global Health schedules AGM

Global Health announced that the 20th Annual General Meeting (AGM) of the company will be ...

Read more

16 Aug 202414:50

News

Global Health to table results

Global Health will hold a meeting of the Board of Directors of the Company on 8 August 202...

Read more

02 Aug 202410:31

News

Global Health acquires land for purpose of building 500-bed hospital in Mumbai

Global Health has been offered by Mumbai Housing and Area Development Authority (MHADA) vi...

Read more

23 Jul 202417:02

News

Global Health to conduct EGM

Global Health announced that an Extra Ordinary General Meeting (EGM) of the Company will b...

Read more

03 Jul 202409:19

Document

Annual Reports

Annual Report 2023

dropdown
download

Credit Ratings

Credit Report 2023

dropdown
download

Concalls

June 2023

TranscriptPPT

Dec 2022

PPT

FAQ's For Global Health Ltd Quarterly Result

What is the EPS of Global Health Ltd stock?

The Earnings Per Share (EPS) of Global Health Ltd is 18.17. An EPS is the amount of net income attributed to each share of a common stock.

How is Global Health Ltd EPS calculated?

The EPS of Global Health Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Global Health Ltd report its EPS?

Global Health Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Global Health Ltd EPS?

Factors that influence the EPS of Global Health Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Global Health Ltd EPS growth indicate future performance?

Yes, consistent growth in Global Health Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*